Novel CRISPR Enzymes and Systems

The European Patent Office published patent application EP4159856A1 for Novel CRISPR Enzymes and Systems, filed by the Broad Institute, MIT, Harvard, and co-applicants including the US Department of Health and Human Services. The patent covers CRISPR-Cas gene editing technology with inventors including Feng Zhang, Sergey Shmakov, and Konstantin Severinov. The application is classified under C12N 15/10 and C12N 9/22.

Aptamers and Uses Thereof - Caris Science Patent

The European Patent Office published patent application EP4170031A1 for Caris Science, Inc., covering aptamer compositions for therapeutic and diagnostic uses. The patent application includes claims for aptamer-based methods and compositions across multiple designated EPC contracting states.

Tobacco Plant Compositions and Methods for Reduced Suckers

The European Patent Office published patent EP4166671A1 for Altria Client Services LLC, covering compositions and methods for producing tobacco plants with reduced or eliminated suckers. The patent application was filed by inventors Payyavula, Shen, Kudithipudi, and Govindarajulu. The publication applies to designated EU member states including Germany, France, the United Kingdom, Italy, Spain, and 23 other European jurisdictions.

Stabilized Fibronectin Domain Compositions, Methods and Uses

The European Patent Office published patent application EP4115911A1 for Janssen Biotech, Inc., covering stabilized fibronectin domain compositions and their therapeutic uses. The patent covers methods for treating neurological, cardiovascular, oncological, hematological, and ocular conditions. This publication grants public access to the patent claims under the EPC designated states.

Oxford University Innovation Patent - Genetic Delivery Composition

The European Patent Office published patent application EP4122498A1 for Oxford University Innovation Limited, covering a novel composition for delivery of genetic material. The patent, published March 25, 2026, includes IPC classifications related to pharmaceutical preparations, proteins, and genetic constructs. The patent is designated across 31 European states including major markets such as Germany, France, and the United Kingdom.

Structure-Based Design of Long-Acting Cocaine Hydrolase Mutants for Treatment

The European Patent Office published patent application EP4262851A1 on March 25, 2026, covering engineered cocaine hydrolase enzyme mutants designed for long-acting treatment of substance use disorders and organophosphorus toxicity. The application was filed by the University of Kentucky Research Foundation with inventors Zhan, Chang-Guo and Zheng, Fang. This A1 publication makes the application publicly available and establishes priority rights.

Particle Classification and Sorting Systems and Methods

The European Patent Office published patent application EP4267938A1 for Engender Technologies Limited, covering particle classification and sorting systems and methods. The invention relates to optical sorting technology with applications in biotechnology and cell analysis. The patent application has been published and is now available for public inspection.

Microorganisms Producing 3-Hydroxypropionic Acid from Glucose

The European Patent Office published patent application EP4242312A1 for LG Chem, Ltd., covering engineered microorganisms capable of producing 3-hydroxypropionic acid from glucose. The patent lists three inventors and covers designated contracting states across the EU and EEA.

Energy Generator with Multifunctional Energy Receptacle Patent

The European Patent Office published patent application EP4259017A1 for Covidien LP's "Energy Generator with Multifunctional Energy Receptacle" on March 25, 2026. The technology relates to medical/surgical energy devices classified under A61B 18/12 and A61B 17/32. Designated states include all EU member states plus Switzerland, UK, and other European Economic Area countries.

Microfilament Insertion Device for Soft Tissue

The European Patent Office published patent EP4259270A1 on March 25, 2026, covering a device for insertion of microfilaments in soft tissue. The patent applicant is Neuronano AB with inventor Jens Shouenborg. The technology relates to medical devices for neurological and electrotherapy applications, designated across 38 European and international states.